You will have the opportunity to advance critical science in areas like basic and applied research and development for new antibiotics, other therapeutics, and vaccines.
Apply to join NIAID’s Sexually Transmitted Infections (STI) Cooperative Research Centers program, which facilitates multidisciplinary and synergistic collaborations to support the development of vaccines aimed to control and prevent STIs.
Apply if your proposed research can 1) advance the discovery and characterization of primary immunodeficiency diseases, 2) understand the causes and mechanisms of disease, 3) enable early detection and molecular diagnosis, and 4) support the development of strategies to treat and eventually cure these disorders.
We do not anticipate Optimize NIH changing the way investigators and grantee institutions work with NIH staff.
The new Hypersensitivity, Allergies, and Mucosal Immunology Special Emphasis Panel ZRG1 IMM-T57 will review applications focused on basic, translational, and clinical immunology and immune mechanisms of hypersensitivities, allergies, and immune responses at the mucosal surfaces.
Read our additional guidance for applicants who must comply with NIH’s policy on enhancing the reproducibility of research findings through increased scientific rigor and transparency.
NIH's overall budget has increased by 8.8 percent, adding $3 billion for a total of $37 billion. The NIAID budget for fiscal year 2018 is $5.3 billion, up by 6.7 percent.
We review several best practices for fellows, like taking initiative in seeking career opportunities, applying without presumption of reviewers’ knowledge, and prioritizing a career development award.
Basic and clinical researchers will collaborate to design and conduct studies of autoimmune disease pathogenesis and mechanisms of action of immune-modulating agents.
Investigators will establish Centers to generate large-scale genomic resources, including sequencing and experimental data, that will be publicly accessible for the infectious disease research community to use.
The Mycobacteriology Laboratory Sourcebook for Harmonization and Support of Tuberculosis (TB) Clinical Trials helps ensure high-quality results and comparability of data across laboratories participating in TB clinical trials.
NIAID is collecting community feedback on how best to leverage Research Resources at the NIH Bethesda Campus, including what services NIAID’s Division of Clinical Research could offer to facilitate better use of those resources.
NIH’s Research Portfolio Online Reporting Tools (RePORT) now includes fiscal year (FY) 2017 data on application, award, and funding totals from across NIH’s institutes and centers.
Share your feedback on how we can best harmonize laboratory animal regulations and policies to reduce the burden on you.
As part of your grant application, you must submit a plan for disseminating NIH-funded clinical trial information that addresses how you will meet the expectations of the NIH Policy on the Dissemination of NIH-Funded Clinical Trial Information.
Check out the recordings, transcripts, and slides from two webinars that the NIH Small Business Program Office hosted in February 2018.
Watch presentations from a conference on cancer, autoimmunity, and immunology for free online this Thursday and Friday.
You should contact a NIAID program officer at least 10 weeks before the receipt date when applying to conduct an investigator-initiated clinical trial (IICT).
Before you apply for NIAID funding, you should first know whether your proposed research includes a select agent and how to proceed if it does.
Soon you can apply to conduct a prospective longitudinal study of the impact of initial influenza exposure on immunity in infants.
NIAID supports three new funding opportunity announcements for administrative supplements on sex/gender influences and populations and underrepresented women's health.
Apply to conduct early stage research capable of developing antigen-specific or highly targeted ways to control autoimmunity in Type 1 diabetes.
Through a recently issued request for information, NIH seeks comments and suggestions on topics under consideration for the first Strategic Plan for Data Science.
NIAID Director Dr. Anthony Fauci discussed the latest budget status, legislative updates, and other information items, including the nomination and impending confirmation of Mr. Alex Azar as HHS Secretary.
Help us gain a comprehensive understanding of the nature, location, and timing of protective immune responses required to prevent initial Mycobacterium tuberculosis (Mtb) infection, latent infection development, and transition to active TB disease.
NIAID is interested in developmental research or interventions that can be incorporated into HIV prevention and treatment interventions or improve their impact.
Send a contract proposal for funds to identify novel adjuvant candidates that can augment the efficacy of human vaccines.
Several NIH institutes seek to extend disaster research beyond documenting the known general risk factors that populations face and their health impact by funding exploratory or developmental research projects.
Join us at the 2018 NIH Regional Seminar on Program Funding and Grants Administration in Washington D.C., from May 2 to 4, to get the inside scoop on topics like grant writing, peer review, and compliance.
Learn about an easy method to find and contact an appropriate NIH program officer for your area of science using NIH RePORTER’s new Matchmaker function.
If you are a next-generation researcher wanting to acquaint yourself with the training programs we offer or a seasoned researcher seeking to get reacquainted, this article describes how to choose the program that’s right for you.
Consider applying for funds to support a team of researchers focused on accelerating HIV vaccine development by addressing key immunogen design roadblocks.
Propose research to develop novel and optimized alternatives to existing in vivo genome editing complexes using funds from a new NIH Common Fund grant opportunity.
The S10 Instrumentation Programs enhance the conduct of NIH-funded biomedical research by funding awards for acquiring state-of-the-art commercially available scientific instruments.
ClinRegs is a public resource for country-specific clinical research regulatory information, covering clinical trial lifecycle, regulatory authority, informed consent, and more.
NIH corrected its application instructions to clarify that you are not required to include the PHS Human Subjects and Clinical Trials Information form for training grants with human subjects.
NIH’s Intent to Pay system may send you an automated deferral email, which does not mean your application was rejected for funding.
Your preliminary research may be the difference between your application’s scoring within or short of NIAID’s paylines.
To accommodate NIH’s new clinical trial policies, the small business innovation research (SBIR) and small business technology transfer (STTR) parent FOAs were each split into two separate FOAs, one that accepts clinical trial applications and one that does not.
Unless otherwise noted in the funding opportunity announcement to which you are applying, you can no longer include clinical trial-related materials in the Appendix of your grant application.